Add Your Heading Text Here

Coronavirus – EMA: Against the fourth dose of the vaccine in the general population

Coronavirus – EMA: Against the fourth dose of...

January 11, 2022

Pfizer: Application to Coreper for a marketing authorization for the coronavirus pill

Pfizer: Application to Coreper for a marketing authorization...

January 10, 2022

EMA: “There is no answer yet” if the Omicron variant requires a new vaccine

EMA: “There is no answer yet” if the...

December 21, 2021

Coreper: Recommends Novavax Covid-19 vaccine to people 18 years of age and older

Coreper: Recommends Novavax Covid-19 vaccine to people 18...

December 20, 2021

Coronavirus: EMA Approves Two New Drugs – Monoclonal, and Immunosuppressive

Coronavirus: EMA Approves Two New Drugs – Monoclonal,...

December 16, 2021

EMA: At two months the booster dose of the Johnson & Johnson vaccine

EMA: At two months the booster dose of...

December 15, 2021

Coronavirus: EMA wants more data on Merck antiviral molnupiravir

Coronavirus: EMA wants more data on Merck antiviral...

December 14, 2021

EMA: The third dose in three months is safe and effective according to the data

EMA: The third dose in three months is...

December 9, 2021

EMA leader: Available vaccines continue to be effective against mutations

EMA leader: Available vaccines continue to be effective...

November 30, 2021

Molnupiravir – EMA: Instructions for using the Merck coronavirus pill

Molnupiravir – EMA: Instructions for using the Merck...

November 19, 2021